https://doi.org/10.1074/jbc.274.26.18470
S
Shrikant Anant
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
481
Papers
12.2K
Citations
63
h-index
162
i10-index
Shrikant Anant is an academic researcher from The University of Kansas Cancer Center. The author has contributed to research in topics: RNA modifications and cancer & Cancer Cells and Metastasis & Epigenetics and DNA Methylation. The author has an h-index of 63, co-authored 409 publications.
ORCID: 0000-0003-4193-3053Papers by this author
worksSpecific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells
1999 · Journal of Biological Chemistry · 1,150 citations
Characterization of Enantiomeric Bile Acid-induced Apoptosis in Colon Cancer Cell Lines
2008 · Journal of Biological Chemistry · 80 citations
https://doi.org/10.1074/jbc.m805804200
Honokiol inhibits melanoma stem cells by targeting notch signaling
2014 · Molecular Carcinogenesis · 76 citations
https://doi.org/10.1002/mc.22242
Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway
2020 · Scientific Reports · 75 citations
https://doi.org/10.1038/s41598-020-57940-9
Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic niche
2021 · Cell Reports · 70 citations
https://doi.org/10.1016/j.celrep.2021.109674
A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells
2012 · OncoImmunology · 50 citations
https://doi.org/10.4161/onci.22089
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat